FDMT 4D Molecular Therapeutics, Inc.
Healthcare$8.60-1.04%ClosedMarket Cap: $449.6M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$33.00
Target (Median)
$33.00
Target Range
$33.00 - $33.00
Upside from current price: 283.7%
Rating Distribution
2 Strong Buy7 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-20 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-19 | RBC Capital | maintain | Outperform | Outperform |
| 2026-03-19 | Chardan Capital | maintain | Buy | Buy |
| 2025-12-18 | Chardan Capital | maintain | Buy | Buy |
| 2025-11-11 | Barclays | maintain | Overweight | Overweight |
| 2025-11-11 | Chardan Capital | maintain | Buy | Buy |
| 2025-11-11 | RBC Capital | maintain | Outperform | Outperform |
| 2025-08-12 | Roth Capital | maintain | Buy | Buy |
| 2025-08-12 | Chardan Capital | maintain | Buy | Buy |
| 2025-07-03 | Chardan Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.72 | $15.2M | 5 |
| Sun Dec 31 | $-3.67 | $41.4M | 4 |
| Mon Dec 31 | $-3.01 | $137.1M | 2 |
| Tue Dec 31 | $-1.91 | $295.9M | 2 |